Identification of N-Hydroxycinnamamide analogues and their bio-evaluation against breast cancer cell lines

Add time:08/21/2019    Source:sciencedirect.com

The present study demonstrates the identification of N-hydroxycinnamamide derivatives and their anticancer potential against human triple-negative breast cancer cell line MDA-MB‑231, MCF-7 and non-malignant origin cell line, HEK-293 (human embryonic kidney). MTT assay was studied with HEK-293 cell line. Anticancer potential of the N-hydroxycinnamamide derivatives were compared with marked drug Tamoxifen through in vitro study. The compound numbers 3b and 3h exhibit most potent activity against antagonistic breast cancer cells (MDA-MB-231) with IC50 13μM and 5μM respectively. Compound 3h promotes DNA fragmentation and induction of apoptosis. Furthermore, loss of mitochondrial membrane potential induced by compound 3h. The major mechanism of compound 3h for anti-breast cancer activity was probably initiation of reactive oxygen species (ROS) in cancer cells thereby persuading apoptotic cell deaths in cancer cells.

We also recommend Trading Suppliers and Manufacturers of N-(m-Benzyloxyphenyl)-alpha-piperidinoacetamide hydrochloride (cas 19515-41-4). Pls Click Website Link as below: cas 19515-41-4 suppliers

Prev:Novel approach toward the morphine skeleton. Synthesis of 1-(5-benzyloxy-2-bromo-4-methoxybenzyl)-6-oxo-3,4,6,7,8,8a-hexahydro-1H-isoquinoline-2-carboxylic acid phenyl ester via N-acylpyridinium salt chemistry
Next:A one-pot selective synthesis of N-Boc protected secondary amines: tandem direct reductive amination/N-Boc protection)